These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28545953)

  • 1. The 2016 revision of the WHO classification of lymphoid neoplasms: The clinician's view.
    Sorigue M; Sancho JM
    Med Clin (Barc); 2018 Jan; 150(2):64-66. PubMed ID: 28545953
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
    Lynch RC; Gratzinger D; Advani RH
    Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2016 revision of the WHO classification of lymphoid neoplasms].
    Tamaru JI
    Rinsho Ketsueki; 2017; 58(10):2188-2193. PubMed ID: 28978864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of the WHO classification of lymphoid neoplasms in the context of the 2016 revision].
    Balhárek T; Marcinek J; Plank L
    Cesk Patol; 2017; 53(3):122-128. PubMed ID: 28937779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    Leonard JP; Martin P; Roboz GJ
    J Clin Oncol; 2017 Aug; 35(23):2708-2715. PubMed ID: 28654364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the diagnosis of lymphomas.
    Soldini D; Campo E
    Ann Oncol; 2012 Sep; 23 Suppl 10():x83-8. PubMed ID: 22987998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
    Cazzola M
    Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
    [No Abstract]   [Full Text] [Related]  

  • 9. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.
    Brown NA; Elenitoba-Johnson KS
    Head Neck Pathol; 2017 Mar; 11(1):96-109. PubMed ID: 28247223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [WHO classification of malignant lymphoma: diagnostic practice and pitfalls].
    Nakamura S
    Rinsho Ketsueki; 2004 Jan; 45(1):15-22. PubMed ID: 14999930
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in the classification of myeloid and lymphoid neoplasms. From REAL to WHO concept.
    Jancar J
    Adv Clin Path; 2000 Apr; 4(2):59-76. PubMed ID: 11185179
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathology and cytodiagnosis of malignant lymphoma--with special reference to WHO, Rappaport, and LSG classification systems].
    Namiki T
    Rinsho Byori; 1982 Jul; 30(7):779-91. PubMed ID: 6757489
    [No Abstract]   [Full Text] [Related]  

  • 13. The World Health Organization classification of lymphomas.
    Jakić-Razumović J; Aurer I
    Croat Med J; 2002 Oct; 43(5):527-34. PubMed ID: 12402390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological diagnosis and classification of lymphoma: present status in China].
    Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):289-90. PubMed ID: 20654149
    [No Abstract]   [Full Text] [Related]  

  • 16. [Review of changes introduced by the new WHO classification (4th edition) of lymphoid malignancies. An overview].
    Tobinai K
    Rinsho Ketsueki; 2009 Apr; 50(4):217-29. PubMed ID: 19404014
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrafollicular neoplasia/"in situ" lymphoma: a proposal for morphology and immunodiagnostic classification.
    Carbone A; Gloghini A
    Am J Hematol; 2011 Aug; 86(8):633-9. PubMed ID: 21674580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of WHO classification and NCCN guidelines in diagnosis of lymphoma].
    Li XH; Sun L; Yuan J
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):217-20. PubMed ID: 19575890
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intention of the new WHO classification (4th edition) of tumors of lymphoid tissue and the main contributions of Japan to this new paradigm].
    Nakamura S
    Rinsho Ketsueki; 2009 Oct; 50(10):1359-64. PubMed ID: 19915343
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
    Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.